BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33420376)

  • 1. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
    Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
    Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
    Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
    Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
    Erdős E; Bálint BL
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.
    Kong SL; Li G; Loh SL; Sung WK; Liu ET
    Mol Syst Biol; 2011 Aug; 7():526. PubMed ID: 21878914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.
    Magnani L; Ballantyne EB; Zhang X; Lupien M
    PLoS Genet; 2011 Nov; 7(11):e1002368. PubMed ID: 22125492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells.
    Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL
    Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.
    Jozwik KM; Chernukhin I; Serandour AA; Nagarajan S; Carroll JS
    Cell Rep; 2016 Dec; 17(10):2715-2723. PubMed ID: 27926873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
    Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
    BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.
    Ying S; Dünnebier T; Si J; Hamann U
    PLoS One; 2013; 8(9):e75695. PubMed ID: 24086615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 13. COUP-TFII is a modulator of cell-type-specific genetic programs based on genomic localization maps.
    Erdős E; Bálint BL
    J Biotechnol; 2019 Aug; 301():11-17. PubMed ID: 31158411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
    Lee JY; Park YJ; Oh N; Kwack KB; Park KS
    Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.
    Kininis M; Chen BS; Diehl AG; Isaacs GD; Zhang T; Siepel AC; Clark AG; Kraus WL
    Mol Cell Biol; 2007 Jul; 27(14):5090-104. PubMed ID: 17515612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas.
    Droog M; Nevedomskaya E; Kim Y; Severson T; Flach KD; Opdam M; Schuurman K; Gradowska P; Hauptmann M; Dackus G; Hollema H; Mourits M; Nederlof P; van Boven H; Linn SC; Wessels L; van Leeuwen FE; Zwart W
    Cancer Res; 2016 Jul; 76(13):3773-84. PubMed ID: 27197147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
    Karmakar S; Jin Y; Nagaich AK
    J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
    Madak-Erdogan Z; Katzenellenbogen BS
    Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover.
    Adomas AB; Grimm SA; Malone C; Takaku M; Sims JK; Wade PA
    BMC Cancer; 2014 Apr; 14():278. PubMed ID: 24758297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.